Technology
NJ20 Carrier Risk Assessment Test is using next-generation sequencing (NGS), the sensitivity is up to 99.9%.
Next Generation Sequencing (NGS)
NJ20 Carrier Risk Assessment Test is using next-generation sequencing (NGS), which is a powerful technology that has enabled the sequencing of thousands to millions of DNA molecules simultaneously. A large number of genes can be screened at the same time, all gene mutations or abnormal sequences can be detected at one time, and the sensitivity is up to 99.9%.
Convenient & Simple
Only 6ml blood in EDTA or 6 swabs can be sufficient for this test
High Quality
First private laboratory owning NGS equipment in Hong Kong